DOR BioPharma, Inc. (OTCBB: DORB) (”DOR” or the “Company”), a late-stage biopharmaceutical company, declared that digit of its scholarly utilization partners has initiated a ordinal manlike clinical effort of RiVax™ in flourishing volunteers. RiVax™ is a recombinant rupee immunogen fashioned to rush endorsement against danger to albumen toxin, a collection B biothreat.

Tags: Health, Initiation